Its Continuing Medical Education (CME) program for doctors on Chronic Traumatic Encephalopathy (CTE) and Cannabis has been approved and accepted by the Accreditation Council for Continuing Medical Education (ACCME) in partnership with the American Medical Association (AMA). Through the course, doctors learn the latest techniques and breakthroughs in CTE research, and fulfill their CME requirements at the same time.
“We are extremely excited to add this CTE protocol to our existing library of medical cannabis accredited courses,” says Dr. Jamison Feramisco, CEO of Alternate Health Corp. “Through our partnership with the University of Louisville, we have created an educational series that instructs doctors how to use cannabis as an emerging treatment for CTE and other medical disorders.”
Launched through Alternate Health’s subsidiary, Alternate Medical Media, the CTE and Cannabis course is the first CME of its kind recognized by the AMA. The course builds on Alternate Medical Media’s previously AMA-approved course on The Endocannabinoid System and Cannabidiol (CBD) and continues to strengthen the company’s research and education assets.